Bioprocessing Application Notes & Case Studies
-
UPLC-MS/MS Determination Of GLP-1 Analogue
7/17/2025
Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.
-
Quantification Of Semaglutide With A Reliable Analytical Method
7/17/2025
Explore a validated LC-MS/MS method for precise Semaglutide quantification in plasma, which features enhanced sensitivity, peak definition, and reproducibility using innovative technologies.
-
Developing A Quantitative Surrogate Peptide Assay
7/17/2025
Discover a streamlined LC-MS/MS workflow for Fc-containing therapeutics like dulaglutide to enable precise quantification with LLOQ as low as 1 ng/mL through automated, efficient assay development.
-
Development Of An Effective LC-MS/MS Cleaning Validation Method
7/17/2025
Gain insight into a robust LC-MS/MS method for quantifying therapeutic peptides that supports contamination control and cleaning validation to ensure product safety and integrity.
-
Bioanalytical Quantification Of A Biotherapeutic Peptide
7/17/2025
Discover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.
-
Optimized Urine Liquid Biopsy Workflow
7/14/2025
Urine-derived cell-free DNA is revolutionizing liquid biopsy research to offer a non-invasive, accessible tool for early disease detection, monitoring, and comprehensive diagnostics across oncology.
-
Liquid Biopsy-Based Detection Of PIK3CA Mutations From cfDNA
7/14/2025
Discover how ultra-sensitive digital PCR workflows use an innovative system to enable precise detection of rare PIK3CA mutations in cfDNA and advance personalized cancer treatment.
-
Detect Ultra-Rare Variants In cfDNA From Liquid Biopsy Samples
7/14/2025
Liquid biopsy, powered by next-generation sequencing, is transforming precision oncology to offer real-time, non-invasive insights into tumor genetics, which revolutionizes how we monitor and manage cancer.
-
Quantifying Lentiviral Physical Titer
7/14/2025
Streamline lentiviral vector analytics with our direct RT-dPCR method. Achieve precise, reproducible results to accelerate safe, effective gene therapies with enhanced quality control.
-
Elevating Downstream Process Development With Real-Time Data Monitoring
7/11/2025
Learn how real-time monitoring with PAT enhances process control, shortens development timelines, and supports the shift toward continuous manufacturing in biopharmaceutical production.